For weight loss clinics building comprehensive metabolic programs.

GLP-1 medications are the most searched treatment in weight management in 2026. Clinics offering semaglutide or tirzepatide alongside CJC-1295/Ipamorelin (for lean muscle preservation) and comprehensive endocrine panels serve a patient population with significantly higher retention and lifetime value than GLP-1-only programs.